Ameritas Investment Partners’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Ameritas Investment Partners’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,231	Closed	-$8K	–	3331
2022 Q1	$8K	Hold	1,231	–	–	﹤0.01%	2876
2021 Q4	$14K	Hold	1,231	–	–	﹤0.01%	2805
2021 Q3	$20K	Hold	1,231	–	–	﹤0.01%	2717
2021 Q2	$23K	Buy	1,231 +766	+165%	+$14.7K	﹤0.01%	2675
2021 Q1	$7K	Hold	465	–	–	﹤0.01%	2963
2020 Q4	$15K	Buy	+465	New	+$6.15K	﹤0.01%	2633

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ameritas Investment Partners's CDAK Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2022, closing a stake of 1,231 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in CDAK in Q4 2020 and held it in 6 quarters. The position peaked at $23K in Q2 2021. 49 funds tracked by Wall St. Rank hold CDAK as of Q2 2022.

Ameritas Investment Partners reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 1,231 Codiak BioSciences, Inc. Common Stock shares in Q2 2022, an estimated $8K.
Ameritas Investment Partners first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Ameritas Investment Partners's Codiak BioSciences, Inc. Common Stock position peaked at $23K in Q2 2021.
49 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.